Effect of Exercise Programme on Gut Microbiota, CVD Risk Factors and Appetite Regulation in Overweight Women
Effect of a 4-week Moderate Intensity Exercise Programme on Gut Microbiota, Cardiovascular Disease Risk Factors and Appetite Regulation in Overweight Women
調査の概要
詳細な説明
Study Design: This is a randomized controlled study with a parallel design. Healthy, sedentary females aged between 18-45 years old will be recruited by means of an advertisement leaflet and word of mouth. Eligible participants will be enrolled in the study and will be randomly allocated to either exercise intervention (EX) or control (C) groups. The EX group will participate in a 4-week exercise intervention and the C group will be asked to continue with habitual life style for 4 weeks. Before and after 4 weeks of the intervention, participants from both groups will be asked to conduct a submaximal exercise test and a 7-hour experimental trial during which blood samples will be collected and metabolic rate will measured before and after consumption of standardized breakfast and lunch. Prior to the first 7-hour trial, participants will be asked to record diet for 3 days and replicate this diet prior to the second 7-hour trial. During these 3 days participants will provide fresh stool samples. Participants allocated to control group will have the option to participate in exercise intervention. A subset of the participants will repeat a 7-hour experimental trial and provide fresh stool and urine sample after 7 days of detraining.
Methods:
Preliminary Health Check: Participants will undertake a health screening questionnaire on the day of recruitment. Participants will also need to fill in Physical Activity Readiness Questionnaire (PARQ). Only participants who answered "no" to all questions in PARQ will conduct the submaximal exercise test.
Anthropometry: All participants will have height, weight and waist circumference measured at baseline and 4 weeks after the intervention.
7-hour Experimental Trial: Participants will attend the metabolic suite (New Lister Building, Glasgow Royal infirmary) in a fasted state at approximately 9.00 am. Participants will be instructed to lie supine on the couch, with the head resting on the pillow provided. Resting metabolic rate will be measured for 20 minutes and fasting blood sample will be obtained. A breakfast meal will be consumed immediately after the fasting sample and a lunch meal after 4 hours. Blood samples will be taken throughout a cannula hourly after breakfast and lunch consumption. Following each blood sample, metabolic rate will be measured for the duration of 20 minutes. Prior each blood sample, participants will fill in appetite questionnaires. Blood samples will be analysed for plasma lipids, glucose, insulin, inflammatory markers and gut appetite hormones using standard existing procedures.
Feacal sample collection & analysis: A disposable stool sample collection kit will be provided prior to the 7-hour trial day. Once collected, the container is sealed and placed in a larger sealable bag with a reducing sachet to remove oxygen and maintain anaerobic bacteria. Stool samples will be measured for changes in gut microbiota based on 16S rRNA amplicon sequencing, bacterial functional capacity and targeted bacterial metabolites (short chain fatty acids, sulphide, ammonia).
Exercise Training Programme: Exercise training will consist of 4 weekly sessions of endurance type exercise (cycling and running) lasting for 30, 40, 50, 60 minutes in the week 1, 2, 3 and 4 respectively. The time and day of each training trial will be agreed between the investigator and the participant and will be based around the participant's availability. All exercise sessions will be supervised by a researcher.
Submaximal Exercise Test: Participants will exercise on treadmill at gradually increasing intensities until 85% of maximal heart rate. During the last minute of each of the intensities heart rate will be measured and expired air will be collected by Douglas bag technique and analysed for oxygen consumption and carbon dioxide production. Relation between heart rate and rate of oxygen consumption will be used to predict maximal oxygen consumption, a marker of cardio-respiratory fitness.
研究の種類
入学 (予想される)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Glasgow、イギリス、G312ER
- 募集
- School of Medicine, University of Glasgow / New Lister Building, Glasgow Royal Infirmary
-
コンタクト:
- Eleni Rizou, BSc MSc
- メール:e.rizou.1@research.gla.ac.uk
-
コンタクト:
- Konstantinos Gerasimidis, BSc MSc PhD
- メール:Konstantinos.Gerasimidis@glasgow.ac.uk
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Healthy, sedentary females, BMI>25 kg/m2, on a stable body weight for the last 3 months
Exclusion Criteria:
- Acute or chronic illness, use of antibiotics the past 3 months, smoking
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:他の
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Exercise
4-week moderate intensity exercise programme
|
4-week moderate intensity exercise programme
|
|
介入なし:Control
4 weeks of habitual life style
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Gut microbiota composition
時間枠:12 months
|
Changes in the gut microbiota composition measured by 16S rRNA amplicon sequencing.
|
12 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Interleukin-6 (IL-6)
時間枠:3 months
|
Changes in fasting and postprandial interleukin-6 pre- and post-interventions measured by Human IL-6 ELISA Ready-Set-Go (Affymetrix, eBioscience)
|
3 months
|
|
Glucose
時間枠:3 months
|
Changes in fasting glucose pre- and post-interventions measured by Randox Glucose
|
3 months
|
|
Triglycerides
時間枠:3 months
|
Changes in fasting and postprandial triglycerides pre- and post-interventions measured by Randox Triglycerides
|
3 months
|
|
Insulin
時間枠:3 months
|
Changes in fasting insulin pre- and post-interventions measured by Mercodia Insulin ELISA
|
3 months
|
|
Peptide YY (PYY)
時間枠:12 months
|
Changes in fasting and postprandial peptide YY pre- and post-interventions measured by Human PYY (Total) ELISA (Merc Millipore)
|
12 months
|
|
Glucagon-like peptide-1 (GLP-1)
時間枠:12 months
|
Changes in fasting and postprandial glucagon-like peptide-1 pre- and post-interventions measured by GLP-1 Total ELISA (Merc Millipore)
|
12 months
|
|
Subjective appetite
時間枠:12 months
|
Changes in subjective appetite (hunger, satiety, fullness, prospective food consumption, desire to eat) pre- and post-interventions measured by Visual Analogue Scales (VAS) where respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points (minimum score is 0 and maximum score is 100)
|
12 months
|
|
Faecal short-chain fatty acids
時間枠:12 months
|
Changes in concentrations of feacal short-chain fatty acids pre- and post-interventions measured by TRACE 2000 Gas Chromatography (ThermoQuest Ltd)
|
12 months
|
|
Faecal pH
時間枠:1 month
|
Changes in feacal pH between pre- and post-intervention measured by Hanna HI 98140
|
1 month
|
|
Body weight
時間枠:1 month
|
Differences in body weight (kilograms) between pre- and post-intervention measured by TANITA scales (TBF-300)
|
1 month
|
|
Height
時間枠:1 month
|
Height (meters) measured by stadiometer, a vertical ruler with a sliding horizontal paddle which is adjusted to rest on the top of the head
|
1 month
|
|
Body fat (kilograms)
時間枠:1 month
|
Differences in body fat expressed in kilograms between pre- and post-intervention measured by TANITA scales (TBF-300)
|
1 month
|
|
Body fat (% percentage)
時間枠:1 month
|
Differences in body fat expressed as percentage (%) (proportion of fat to the total body weight) between pre- and post-intervention measured by TANITA scales (TBF-300)
|
1 month
|
|
Body Mass Index (BMI)
時間枠:1 month
|
Differences in body mass index (weight and height will be combined to report BMI in kg/m^2) between pre- and post-intervention measured by TANITA scales (TBF-300)
|
1 month
|
|
Dietary Intake
時間枠:6 months
|
Energy intake and macro nutrient intake using WinDiets software based on food composition tables
|
6 months
|
|
Maximum Oxygen Consumption
時間枠:2 weeks
|
Maximum Oxygen Consumption (ml/kg/min) measured before and after the interventions by Servomex Gas Analyser
|
2 weeks
|
|
Energy substrate oxidation
時間枠:6 months
|
Fat and carbohydrate oxidation in the fasted and postprandial state measured before and after the interventions using indirect calorimetry (Oxycon Pro)
|
6 months
|
|
Resting Metabolic Rate
時間枠:2 month
|
Resting metabolic rate was measured before and after the interventions (Oxycon Pro)
|
2 month
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Konstantinos Gerasimidis, BSc MSc PhD、University of Glasgow
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (予想される)
研究の完了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
太りすぎと肥満の臨床試験
-
Swansea University完了A Bite of ACT' (BOA) Acceptance and Commitment Therapy オンライン心理教育コース | 待機リスト コントロールイギリス
-
Truway Health, Inc.まだ募集していません地球外居住システム | 月面居住 | 月面水氷資源評価 | イン・シチュー資源利用 (ISRU) | 月面ゲートウェイ輸送アーキテクチャ | 火星表面居住準備性 | 環境制御及び生命維持システム(ECLSS) | 放射線被ばくモデリング | EVA Logistics and Mobility | 長期間隔離と行動の安定性アメリカ
Exerciseの臨床試験
-
National Taiwan Normal University完了
-
University of Erlangen-Nürnberg Medical SchoolKlinikum Nürnberg完了
-
University of TorontoUniversity Health Network, Toronto; University of Western Ontario, Canada; Institute for Clinical... と他の協力者完了
-
Chonticha KaewjohoUniversity of Phayao完了
-
Shanghai Jiao Tong University School of Medicine完了